Can two therapies beat one for stroke neglect?

NCT ID NCT07157865

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares prism adaptation training (PAT) alone versus PAT combined with mild electrical stimulation (TENS) in 20 stroke survivors who have unilateral spatial neglect—a condition where they ignore one side of their body. The goal is to see if the combination improves attention and arm movement more than PAT alone. Participants will be assessed using standard tests before and after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
prism adaptation training and transcutaneous electrical nerve stimulation (TENS)
What this could lead to
If it works, this could point toward a better rehabilitation method for stroke survivors who ignore one side of their body.
What could go wrong
This is a very small early study with only 20 people, so results may not apply to everyone. Combining treatments may not provide extra benefit over standard therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kettering Health NeuroRehab and Balance Center

    NOT_YET_RECRUITING

    Centerville, Ohio, 45459, United States

  • Kettering Health NeuroRehab and Balance Center

    RECRUITING

    Centerville, Ohio, 45459, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.